Laparoscopic Hysterectomy With Vaginal Vault Suspension to the Uterosacral Ligaments for Stage II-III Pelvic Organ Prolapse.
NCT ID: NCT03553511
Last Updated: 2021-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2022-05-31
2024-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Techniques available to manage PHVP aim to ultimately suspend the vaginal vault. Approaches include vaginal, e.g. uterosacral ligament suspension, sacrospinous ligament fixation, open procedures and more recently laparoscopic, e.g. sacrocolpopexy and uterosacral plication.
Data published so far do not allow to draw a firm conclusion about the best treatment to prevent PHVP for women undergoing hysterectomy for stage II-III pelvic organ prolapse. Considering this scenario, in the current study the investigators aim to evaluate short and long-term outcomes after total laparoscopic hysterectomy with vaginal vault suspension to the uterosacral ligaments versus vaginal hysterectomy with McCall culdoplasty for the treatment of stage II-III pelvic organ prolapse.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Two Apical Repair Methods in Women Undergoing Repairs for Prolapse
NCT03113513
Prophylactic Laparoscopic Suspension After McCall
NCT04560543
Prophylactic Uterosacral Ligament Suspension at the Time of Hysterectomy for Prevention of Vaginal Vault Prolapse
NCT01364025
Patient-Centered Outcomes in the Surgical Treatment of Uterovaginal Prolapse
NCT05063331
Apical Suspension Repair for Vault Prolapse In a Three-Arm Randomized Trial Design
NCT02676973
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Uterosacral ligaments suspension
Women affected by stage II-III pelvic organ prolapse undergoing total laparoscopic hysterectomy with vaginal vault suspension to the uterosacral ligaments.
Vaginal vault suspension to the uterosacral ligaments
Laparoscopic hysterectomy with vaginal vault suspension to the uterosacral ligaments
McCall culdoplasty
Women affected by stage II-III pelvic organ prolapse undergoing vaginal hysterectomy with McCall culdoplasty.
McCall culdoplasty
Vaginal hysterectomy with McCall culdoplasty
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vaginal vault suspension to the uterosacral ligaments
Laparoscopic hysterectomy with vaginal vault suspension to the uterosacral ligaments
McCall culdoplasty
Vaginal hysterectomy with McCall culdoplasty
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Bilateral preservation of the ovaries
* Sexually active women
Exclusion Criteria
* Body Mass Index \> 30
* Strenuous activity (frequent heavy lifting)
* Other gynecological and non-gynecological (chronic endocrine, metabolic, autoimmune, neoplastic diseases) comorbidities
* Pharmacological and/or nonpharmacological treatment (including pelvic floor exercises) in the six months preceding the surgery or during the study period
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Università degli Studi dell'Insubria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonio Simone Laganà
Medical Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antonio Simone Laganà, M.D.
Role: PRINCIPAL_INVESTIGATOR
Università degli Studi dell'Insubria
Jvan Casarin, M.D.
Role: PRINCIPAL_INVESTIGATOR
Università degli Studi dell'Insubria
Antonella Cromi, M.D., Ph.D.
Role: STUDY_CHAIR
Università degli Studi dell'Insubria
Fabio Ghezzi, M.D.
Role: STUDY_DIRECTOR
Università degli Studi dell'Insubria
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LULS-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.